Poland· PL-100098770

Pronoran

A piribedil product containing piribedilum, registered in Poland by Les Laboratoires Servier. The same ATC class is registered in 3 of our 19 countries.

ATC N04BC08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPronoranATCN04BC08REGISTER NO.PL-100098770PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Piribedil is registered in 3 of 19 countries.

Countries holding a registration under ATC N04BC08 (piribedil), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 1 of them publish a price we can compare per daily dose

Piribedil · ATC N04BC08

3 / 19 countries

  • Germany
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Piribedilum
Manufacturer
Les Laboratoires Servier
Country
Poland (PL)
ATC code
N04BC08
ATC class
Piribedil
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05909990846320
    30 szt.
    PLN 27.77
  • gtin
    05909990846313

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Piribedil in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piribedil products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Clarium
  • France · Trivastal
  • Lithuania · Pronoran
  • Luxembourg · Trivastal
  • Portugal · Trivastal Retard
  • Romania · Pronoran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bac5e155-da89-438d-9f55-500cd4657e9f
GET /v1/drugs/bac5e155-da89-438d-9f55-500cd4657e9f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909990846313 ¦ Rp ¦ 16925\n30 tabl. w blistrze (1 x 30)\n05909990846320 ¦ Rp ¦ 19636\n30 tabl. w blistrach (2 x 15)",
  "substance": "Piribedilum 50 mg",
  "common_name": "Piribedilum",
  "pl_product_id": "100098770",
  "pozwolenie_nr": "08463",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about piribedil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.